CIRM approves $2.5 million to establish a Patient Support Program 

Hataalii Tiisyatonii Begay (HT) participated in a CIRM-funded clinical trial at UCSF for Artemis-SCID, a condition that can be life-threatening or fatal. Photo courtesy Barbara Ries / UCSF.  The California Institute for Regenerative Medicine (CIRM) funds innovative cell and gene therapy research and educational programs to advance regenerative medicine in the Golden State. Just as … Continue reading CIRM approves $2.5 million to establish a Patient Support Program 

Identifying a Potential New Stem Cell Treatment for Ovarian Cancer

Stock image of a uterus and ovaries model. The California Institute for Regenerative Medicine (CIRM) has awarded a $5.3 million to Karen Aboody, MD of City of Hope for late-stage preclinical research to develop a neural stem cell mediated treatment for a chemo-resistant, metastatic ovarian cancer. Approximately 22,000 women are diagnosed with ovarian cancer—the most … Continue reading Identifying a Potential New Stem Cell Treatment for Ovarian Cancer

Advancing Clinical Research for a CAR T-Cell Therapy for Systemic Lupus Erythematosus (SLE), Autoimmune Diseases

Symptoms of lupus may include pain or swelling in the joints, extreme fatigue, a butterfly rash on the cheeks and nose, and more. The California Institute for Regenerative Medicine (CIRM) has awarded $7.9 million to Barbara Hickingbottom, MD, of Fate Therapeutics to advance clinical research for FT819, an induced pluripotent stem cell (iPSC)-derived CD19 CAR … Continue reading Advancing Clinical Research for a CAR T-Cell Therapy for Systemic Lupus Erythematosus (SLE), Autoimmune Diseases

CIRM Funds Clinical Research for Individualized Stem Cell Treatment for Parkinson’s

Stock image of Parkinson's disease nerve cells. The California Institute for Regenerative Medicine (CIRM) has approved an $8 million award to Aspen Neuroscience to advance an investigational stem cell-derived dopaminergic neuron replacement therapy for Parkinson’s disease (PD). This individualized potential therapy is being explored in a first-in-human Phase 1/2a clinical trial for patients with moderate … Continue reading CIRM Funds Clinical Research for Individualized Stem Cell Treatment for Parkinson’s

Former CIRM Bridges Intern Receives Rising Black Scientist Award

Photo Credit: California State University, San Marcos. Cal State San Marcos cellular and molecular biology student and former California Institute for Regenerative Medicine (CIRM) Bridges intern Kevin Brown Jr. has been awarded the Rising Black Scientist Award from the journal Cell Press, Cell Signaling Technology (CST), and the Elsevier Foundation. Brown was selected from a pool … Continue reading Former CIRM Bridges Intern Receives Rising Black Scientist Award

Celebrating Black Joy and Spreading Awareness 

The streets of Oakland were alive with vibrant colors, infectious energy, and a powerful sense of community as the 2024 Black Joy Parade took center stage on Sunday, February 25.  Black Joy Parade-goers with colorful noisemakers walking down Franklin and 19th St. The Black Joy Parade is a yearly celebration of the Black community and … Continue reading Celebrating Black Joy and Spreading Awareness 

CIRM celebrates landmark 100+ clinical trial awards 

Photo credit: Barbara Ries for UCSF, Jaquell Chandler, and OHSU/Christine Torres Hicks  The California Institute for Regenerative Medicine (CIRM), California’s Stem Cell Agency and the world’s largest institution dedicated to regenerative medicine reached a milestone when it approved funding for its 100th clinical trial. At the February Independent Citizens’ Oversight Committee (ICOC) meeting, the board … Continue reading CIRM celebrates landmark 100+ clinical trial awards 

CIRM Awards $21.3 Million to Foster Collaboration Through Shared Labs

Shared resources, including state-of-the art lab equipment and expertise, foster collaboration (above). Photo courtesy of UCLA Broad Stem Cell Research Center.  The California Institute for Regenerative Medicine (CIRM) has approved awarding $21.3 million to create a network of Shared Resources Laboratories (SRLs) for Stem Cell-Based Modeling. The SRLs are an important component of CIRM’s Infrastructure … Continue reading CIRM Awards $21.3 Million to Foster Collaboration Through Shared Labs

CIRM awards more than $56 million for clinical research aimed at treating Parkinson’s disease, autoimmune conditions and a variety of cancers

The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, awarded $56 million to fund various clinical research aimed at treating Parkinson’s disease, autoimmune conditions and a variety of cancers. The awards will support seven projects—five clinical trials and two preclinical projects—in the Agency’s clinical program which provides funding for … Continue reading CIRM awards more than $56 million for clinical research aimed at treating Parkinson’s disease, autoimmune conditions and a variety of cancers

Neurona Therapeutics Raises $120M Financing, Cell Therapy Shows Positive Outcomes in CIRM-Funded Trial

Photo Courtesy of Neurona Therapeutics/Curtis Myers Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, recently announced the successful completion of a $120 million financing.   Neurona’s financial success is an encouraging sign for the stem cell and gene therapy sector, highlighting partnerships with investors and public organizations … Continue reading Neurona Therapeutics Raises $120M Financing, Cell Therapy Shows Positive Outcomes in CIRM-Funded Trial